|
|
Roadmap - Questionaire Responses for AA CAMP 2004 |
Back to
index
(editors)
Back to
index
(techies/administrators)
Add new suggestion
(editors)
Add new suggestion
(techies/administrators)
1. Main problems and annoyances you encounter when using ActionApps
Please wait http://duocppphar.com/zithromax-monodose-250-mg-eyrh zithromax monodose 250 mg A phase III trial involving 1,307 patients showed that secukinumab was more effective than Enbrel in clearing skin in patients with moderate to severe plaque-type psoriasis, a painful and unsightly skin condition that causes itching and scaling.
2. Features suggested for future development versions of ActionApps
Please wait http://duocppphar.com/zithromax-monodose-250-mg-eyrh zithromax monodose 250 mg A phase III trial involving 1,307 patients showed that secukinumab was more effective than Enbrel in clearing skin in patients with moderate to severe plaque-type psoriasis, a painful and unsightly skin condition that causes itching and scaling.
3. Comments About Usablility
Please wait http://duocppphar.com/zithromax-monodose-250-mg-eyrh zithromax monodose 250 mg A phase III trial involving 1,307 patients showed that secukinumab was more effective than Enbrel in clearing skin in patients with moderate to severe plaque-type psoriasis, a painful and unsightly skin condition that causes itching and scaling.
4. General future development suggestions
n/a
Submited by:
evnoaWEsttchW
|
 |
APC
ActionApps is a free software content management system initiated by
the Association for Progressive Communications (APC) APC - Internet and ICTs for social justice and development |